Cargando…
Cytokine Secretion Dynamics of Isolated PBMC after Cladribine Exposure in RRMS Patients
Cladribine (CLD) treats multiple sclerosis (MS) by selectively and transiently depleting B and T cells with a secondary long-term reconstruction of the immune system. This study provides evidence of CLD’s immunomodulatory role in peripheral blood mononuclear cells (PBMCs) harvested from 40 patients...
Autores principales: | Balasa, Rodica, Maier, Smaranda, Hutanu, Adina, Voidazan, Septimiu, Andone, Sebastian, Oiaga, Mirela, Manu, Doina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499495/ https://www.ncbi.nlm.nih.gov/pubmed/36142168 http://dx.doi.org/10.3390/ijms231810262 |
Ejemplares similares
-
Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients – An In Vitro Study
por: Dobreanu, Minodora, et al.
Publicado: (2021) -
Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab
por: Maier, Smaranda, et al.
Publicado: (2020) -
Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients
por: Moţăţăianu, Anca, et al.
Publicado: (2018) -
The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients
por: Romaniuc, Andreea, et al.
Publicado: (2020) -
Predictors of Depression in Caucasian Patients with Amyotrophic Lateral Sclerosis in Romania
por: Anca, Motataianu, et al.
Publicado: (2020)